FERDEGHINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.137
EU - Europa 434
AS - Asia 157
AF - Africa 36
OC - Oceania 2
Totale 1.766
Nazione #
US - Stati Uniti d'America 1.114
IT - Italia 155
SE - Svezia 83
CN - Cina 82
BG - Bulgaria 49
DE - Germania 33
AT - Austria 26
CI - Costa d'Avorio 25
GB - Regno Unito 24
TR - Turchia 23
CA - Canada 22
UA - Ucraina 19
VN - Vietnam 18
FI - Finlandia 17
SG - Singapore 17
BE - Belgio 16
HK - Hong Kong 9
SN - Senegal 8
CH - Svizzera 5
IN - India 5
HU - Ungheria 3
NG - Nigeria 3
FR - Francia 2
JP - Giappone 2
AD - Andorra 1
AU - Australia 1
IE - Irlanda 1
IR - Iran 1
MX - Messico 1
NZ - Nuova Zelanda 1
Totale 1.766
Città #
Ann Arbor 167
Woodbridge 160
Chandler 135
Houston 134
Fairfield 93
Ashburn 80
Milan 58
Sofia 49
Beijing 39
Seattle 36
Serra 36
Wilmington 34
Cambridge 28
Jacksonville 26
New York 26
Abidjan 25
Princeton 25
Izmir 22
Ottawa 22
Vienna 21
Lawrence 18
Brussels 16
Medford 16
Nanjing 14
Des Moines 11
Dong Ket 9
Dakar 8
Hong Kong 8
Lancaster 8
Nanchang 8
Bremen 7
Florence 7
Washington 7
Frankfurt am Main 6
Kunming 6
San Diego 6
Hebei 5
Jüchen 5
Norwalk 5
Rome 5
Bern 4
Leawood 4
Naples 4
Boulder 3
Dearborn 3
Lagos 3
London 3
Messina 3
Pisa 3
Pune 3
San Mateo 3
Changsha 2
Düsseldorf 2
Grafing 2
Jiaxing 2
Jinan 2
San Francisco 2
Singapore 2
Andorra la Vella 1
Ardabil 1
Auburn Hills 1
Birmingham 1
Boardman 1
Central 1
Christchurch 1
Costa Mesa 1
Council Bluffs 1
Dublin 1
Guangzhou 1
Harlow 1
Hefei 1
Islington 1
Marseille 1
Mexico City 1
Mountain View 1
Mumbai 1
Ningbo 1
Ogden 1
Redwood City 1
Shenyang 1
Solferino 1
Sydney 1
Tappahannock 1
Tokyo 1
Verona 1
Totale 1.468
Nome #
OFF-LABEL USE OF SUNITINIB IN PATIENTS WITH ADVANCED EPITHELIAL THYROID CANCER: A RETROSPECTIVE ANALYSIS 136
Effect of 1-year treatment with interferon-beta 1b on thyroid function and autoimmunity in patients with multiple sclerosis 135
Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas 131
Oxidative and genotoxic damage after radio-iodine therapy of Graves' hyperthyroidism 122
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between rhTSH stimulation and prolonged levothyroxine withdrawal 119
Haematic coenzyme Q10 and vitamin E levels after treatment with 131I in patients affected by thyroid cancer 114
Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement? 109
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis. 107
131-I treatment of Graves' disease reduces plasma alpha-tocopherol and induces micronuclei and clastogenic factor 100
Nodulo tiroideo autonomo e iniezione percutanea di etanolo 90
null 89
Claudin-1 and-7 Expression in Solid Cell Nests of the Thyroid: An Enigmatic Analogy with Papillary Carcinoma 79
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: Is there a role for serum thyroglobulin measurement? 74
Claudin Proteins, PAX8 and NIS Immunohistochemical Evaluation in Human Fetal Thyroid Development 73
rhTSH-Stimulated Postsurgical Thyroid Remnant Ablation in Differentiated Thyroid Cancer: 1.85 vs 3.7 GBq I-131 Activity 69
Claudins-1,3,4,5 and-7 expression during human thyroid development: an immunohistochemical analysis 69
Regulation of tight junction proteins during the epithelial-mesenchymal transition in thyroid cancer: the role of the slug transcription factor 63
Age and gender substantially influence the relationship between thyroid status and lipoprotein profile: results from a large cross-sectional study 56
Le adipochine: struttura, funzione e significato clinico 47
Totale 1.782
Categoria #
all - tutte 3.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201998 0 0 0 0 0 0 0 0 2 36 33 27
2019/2020262 34 23 39 11 22 20 28 15 20 20 26 4
2020/2021113 9 4 7 4 17 0 5 15 10 9 15 18
2021/2022202 5 19 3 14 35 19 4 10 4 13 13 63
2022/2023370 36 63 18 38 27 55 7 25 69 3 21 8
2023/2024232 30 26 35 23 47 55 11 3 2 0 0 0
Totale 1.782